LONG ISLAND, N.Y., Sept. 6, 2018 /PRNewswire-PRWeb/ -- AccuVein Inc., the global leader in vein visualization, announced today that it will be showcasing
The study completed by JoAnn Barreras, RN, CPN, ADN and Todd P. Chang, MD, MAcM from Children's Hospital Los Angeles, Keck School of Medicine at University of Southern California, looked at almost 8,000 peripheral venous access placements in children. It found that AccuVein's NIR technology, which provides a map of the patient's vasculature on the skin's surface "significantly increases intravenous line placement success rates compared with visualization or palpation."
These improvements using the AccuVein AV400 are corroborated in other studies in which the vein finder has been shown to improve first stick success by a striking 350%, reduce pain by up to 59% and reduce procedure time by 78%.
AccuVein will be demonstrating their award winning vein illumination technology at booth #218. The poster study will be on display at AVA 2018 on electronic screens in the lobby and in the exhibit hall.
About AccuVein Inc. AccuVein Inc. is the global leader in vein visualization technology. AccuVein's flagship product, the AV400, is the world's only hand-held, non-contact vein illumination solution. The device has won numerous awards including the prestigious Prism Award for Photonics Innovation. Healthcare professionals see a map of peripheral veins directly on the skin's surface with the goal of accessing or avoiding veins. It is built on proprietary technology embodied in its growing patent portfolio on a broad range of imaging and medical diagnostic technologies. AccuVein is in use at more than 5,000 facilities and available for sale in over 130 countries worldwide. To see a demonstration of AccuVein in action, please visit http://www.accuvein.com.
Subscribe to our Free Newsletters!